ImmunoGenesis
Biotechnology company developing novel immunotherapy approaches for cancer treatment, with focus on enhancing immune cell function to fight tumors.
Location
Philadelphia, Pennsylvania, USA
Founded
2018
Categories
biotech, immunotherapy, oncology, cell-therapy
Notes
ImmunoGenesis is a biotechnology company focused on developing novel immunotherapy approaches for cancer treatment. The company is working on technologies to enhance the ability of the immune system to recognize and destroy cancer cells.
Based in the Philadelphia area, ImmunoGenesis is backed by BioAdvance, a life sciences investment organization focused on early-stage companies in the Mid-Atlantic region. The company is developing approaches that may complement or improve upon existing immunotherapy modalities like checkpoint inhibitors and CAR-T cell therapy.
Team
- Leadership team with immunology and oncology drug development experience
Additional Research Findings
- Founded circa 2018, based in Philadelphia area
- Portfolio company of BioAdvance
- Immunotherapy focus for cancer
- Early-stage development company
- Enhancing immune cell function
- Part of Philadelphia biotech ecosystem
- Pre-clinical to early clinical stage